Cargando…

Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events

INTRODUCTION: Immunotherapies have improved the prognosis of many cancer patients including patients with advanced melanoma. Immune checkpoint receptors including CTLA-4 and PD-1 have been established as main therapeutic targets for immunotherapy of melanoma. Although monotherapy is effective in mel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Benjamin, Bärenwaldt, Anne, Herzig, Petra, Zippelius, Alfred, Maul, Lara Valeska, Hess, Viviane, König, David, Läubli, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130408/ https://www.ncbi.nlm.nih.gov/pubmed/37122748 http://dx.doi.org/10.3389/fimmu.2023.1125111

Ejemplares similares

Pembrolizumab-induced optic neuropathy – a case report
por: Daetwyler, Eveline, et al.
Publicado: (2023)

Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown
por: Kostner, Lisa, et al.
Publicado: (2022)

Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer
por: Wang, Jinyu, et al.
Publicado: (2022)

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
por: Läubli, Heinz, et al.
Publicado: (2015)

Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
por: Trinh, Beckey, et al.
Publicado: (2019)

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
por: Läubli, Heinz, et al.
Publicado: (2018)

Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
por: Rodrigues Mantuano, Natalia, et al.
Publicado: (2020)

Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
por: Ortega Sanchez, Guacimara, et al.
Publicado: (2018)

Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort
por: Conen, Katrin, et al.
Publicado: (2016)

Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
por: Läubli, Heinz, et al.
Publicado: (2019)

Editorial: Novel roles for tumor-associated neutrophils
por: Mandruzzato, Susanna, et al.
Publicado: (2022)

Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies
por: Trüb, Marta, et al.
Publicado: (2021)

A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration
por: Werner, Franziska, et al.
Publicado: (2021)

Nivolumab-induced diabetes mellitus—a case report with literature review of the treatment options
por: Daetwyler, Eveline, et al.
Publicado: (2023)

Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs
por: Martin, Kea, et al.
Publicado: (2015)

An Integrated View on Neuronal Subsets in the Peripheral Nervous System and Their Role in Immunoregulation
por: Jakob, Manuel O., et al.
Publicado: (2021)

Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience
por: Hagmann, Raphael, et al.
Publicado: (2015)

Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis
por: Liu, Dong, et al.
Publicado: (2021)

Targeting immunoliposomes to EGFR-positive glioblastoma
por: Kasenda, B., et al.
Publicado: (2022)

Editorial: Glycans: Masters of immunity, from cancers to inflammatory disease
por: Beatson, Richard, et al.
Publicado: (2022)

Human Miscarriage Is Associated With Dysregulations in Peripheral Blood-Derived Myeloid Dendritic Cell Subsets
por: Ehrentraut, Stefanie, et al.
Publicado: (2019)

Phenotypic Changes of Peripheral γδ T Cell and Its Subsets in Patients With Coronary Artery Disease
por: Li, Yan, et al.
Publicado: (2022)

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
por: Läubli, Heinz, et al.
Publicado: (2017)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events
por: Müller-Jensen, Leonie, et al.
Publicado: (2023)

BCG and Adverse Events in the Context of Leprosy
por: Richardus, Renate, et al.
Publicado: (2018)

Single-Cell Transcriptomic Analyses Define Distinct Peripheral B Cell Subsets and Discrete Development Pathways
por: Stewart, Alexander, et al.
Publicado: (2021)

Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis
por: Liu, Pen-Ju, et al.
Publicado: (2023)

Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2022)

Comparison of T and NK lymphocyte subsets between human endometrial tissue and peripheral blood
por: Chernyshov, Viktor P., et al.
Publicado: (2019)

Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical Relevance
por: Matić, Ivana Z., et al.
Publicado: (2018)

Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
por: Miao, Kang, et al.
Publicado: (2022)

The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy
por: Zhou, Jin, et al.
Publicado: (2022)

On the Dark Side of Therapies with Immunoglobulin Concentrates: The Adverse Events
por: Späth, Peter J., et al.
Publicado: (2015)

Immune-related adverse events: A bibliometric analysis
por: Jiang, Shi-Tao, et al.
Publicado: (2022)

Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients
por: Mahmood, Zafar, et al.
Publicado: (2020)

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer
por: Ottonello, Selene, et al.
Publicado: (2020)

Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non– small cell lung cancer
por: Miao, Kang, et al.
Publicado: (2022)

Immunogenic change after percutaneous microwave ablation in pulmonary malignancies: Variation in immune cell subsets and cytokines in peripheral blood
por: Zhang, Liang, et al.
Publicado: (2022)

The Ontogeny of Monocyte Subsets
por: Wolf, Anja A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qni6a7jqgg1erib74cmj0cnprb